ATMPH 2020
DOI: 10.36295/asro.2020.23722
|View full text |Cite
|
Sign up to set email alerts
|

The immunological response toward botulinum toxin in individuals with facial rejuvenation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The present study discovered that the insignificant increase in the IL-17 level could imply the absence of post-injection inflammatory response, which provides insight into the safety of BOTOX, HA filler, and the combination of both. Furthermore, other researchers found that serum IL-2, IL-6, and IL-8 levels, cytokines that promote the production of IL-17, were significantly higher in subjects who received BOTOX injections than in control (33).…”
Section: Discussionmentioning
confidence: 92%
“…The present study discovered that the insignificant increase in the IL-17 level could imply the absence of post-injection inflammatory response, which provides insight into the safety of BOTOX, HA filler, and the combination of both. Furthermore, other researchers found that serum IL-2, IL-6, and IL-8 levels, cytokines that promote the production of IL-17, were significantly higher in subjects who received BOTOX injections than in control (33).…”
Section: Discussionmentioning
confidence: 92%